Asarfi Hospital Ltd
Incorporated in 2005, Asarfi Hospital Ltd
provides primary health services & treatment
and specialized super speciality health service[1]
- Market Cap ₹ 166 Cr.
- Current Price ₹ 84.3
- High / Low ₹ 108 / 52.8
- Stock P/E 25.2
- Book Value ₹ 38.0
- Dividend Yield 0.00 %
- ROCE 11.4 %
- ROE 7.50 %
- Face Value ₹ 10.0
Pros
Cons
- Though the company is reporting repeated profits, it is not paying out dividend
- Debtor days have increased from 76.4 to 109 days.
* The pros and cons are machine generated. Pros / cons are based on a checklist to highlight important points. Please exercise caution and do your own analysis.
Peer comparison
Sector: Healthcare Industry: Healthcare
Half Yearly Results
Standalone Figures in Rs. Crores / View Consolidated
Profit & Loss
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | TTM | |
---|---|---|---|---|---|---|
42.87 | 54.12 | 65.19 | 68.81 | 80.93 | 97.86 | |
36.63 | 46.08 | 54.41 | 55.04 | 64.61 | 78.24 | |
Operating Profit | 6.24 | 8.04 | 10.78 | 13.77 | 16.32 | 19.62 |
OPM % | 14.56% | 14.86% | 16.54% | 20.01% | 20.17% | 20.05% |
0.29 | 0.28 | 0.98 | 2.33 | 1.67 | 2.60 | |
Interest | 0.53 | 0.63 | 0.70 | 1.34 | 2.92 | 2.92 |
Depreciation | 2.42 | 2.91 | 3.35 | 3.87 | 8.78 | 10.74 |
Profit before tax | 3.58 | 4.78 | 7.71 | 10.89 | 6.29 | 8.56 |
Tax % | 26.54% | 25.94% | 25.81% | 26.35% | 33.07% | |
2.63 | 3.53 | 5.73 | 8.02 | 4.21 | 6.57 | |
EPS in Rs | 21.48 | 28.83 | 46.79 | 5.53 | 2.14 | 3.34 |
Dividend Payout % | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Compounded Sales Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 14% |
TTM: | 18% |
Compounded Profit Growth | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 6% |
TTM: | -47% |
Stock Price CAGR | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | % |
1 Year: | -17% |
Return on Equity | |
---|---|
10 Years: | % |
5 Years: | % |
3 Years: | 17% |
Last Year: | 8% |
Balance Sheet
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | Sep 2024 | |
---|---|---|---|---|---|---|
Equity Capital | 1.25 | 1.25 | 1.25 | 14.50 | 19.68 | 19.68 |
Reserves | 12.12 | 15.65 | 21.38 | 27.36 | 50.78 | 55.02 |
5.44 | 7.13 | 11.63 | 17.20 | 31.91 | 43.92 | |
8.83 | 13.26 | 28.45 | 34.36 | 51.70 | 39.69 | |
Total Liabilities | 27.64 | 37.29 | 62.71 | 93.42 | 154.07 | 158.31 |
18.40 | 22.42 | 30.87 | 38.57 | 93.71 | 89.26 | |
CWIP | 0.19 | 1.62 | 9.34 | 17.91 | 0.00 | 0.58 |
Investments | 0.00 | 0.00 | 0.00 | 0.00 | 0.01 | 0.01 |
9.05 | 13.25 | 22.50 | 36.94 | 60.35 | 68.46 | |
Total Assets | 27.64 | 37.29 | 62.71 | 93.42 | 154.07 | 158.31 |
Cash Flows
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
2.42 | 10.29 | 9.26 | 7.33 | 25.92 | |
-4.84 | -16.00 | -23.16 | -21.34 | -63.03 | |
2.42 | 6.00 | 13.77 | 15.11 | 36.41 | |
Net Cash Flow | 0.00 | 0.29 | -0.13 | 1.10 | -0.71 |
Ratios
Standalone Figures in Rs. Crores / View Consolidated
Mar 2020 | Mar 2021 | Mar 2022 | Mar 2023 | Mar 2024 | |
---|---|---|---|---|---|
Debtor Days | 20.01 | 14.16 | 29.84 | 89.80 | 109.41 |
Inventory Days | 23.12 | 13.20 | 15.50 | 25.89 | 32.33 |
Days Payable | 155.80 | 22.69 | 34.13 | 90.98 | 445.29 |
Cash Conversion Cycle | -112.67 | 4.67 | 11.22 | 24.72 | -303.55 |
Working Capital Days | 18.05 | -7.15 | -4.20 | 51.56 | -3.02 |
ROCE % | 25.26% | 28.86% | 26.19% | 11.41% |
Documents
Announcements
-
Announcement under Regulation 30 (LODR)-Earnings Call Transcript
9 Nov - Transcript of Half Year FY2024-25 earnings conference call.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome
6 Nov - Outcome of Investors/Analysts Meet held on Nov 6, 2024.
-
Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation
1 Nov - Investor meeting scheduled for November 6, 2024.
-
Intimation Of Material Event - Possession & Registry Of Land.
1 Nov - Possession and registry of land for expansion.
-
Announcement under Regulation 30 (LODR)-Investor Presentation
30 Oct - Investor Presentation for the Half Year ended Sept 30''2024.
Annual reports
Concalls
-
Nov 2024Transcript PPT
Business Overview Asarfi Hospital Limited (AHL) operates three primary facilities:
Pharmacy Contribution: The hospital’s pharmacy contributed 25% of the revenue
Asarfi Cancer Institute (Ranguni, Dhanbad)[2]
Future Expansion: The facility is approved for construction of up to seven floors, enabling substantial expansion.
Research Institute (Ranchi)[3]